Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma-data from the prospective German Tumour Registry Lymphatic Neoplasms.

Wolfgang KnaufWolfgang AbenhardtJohannes MohmJacqueline RauhJohanna HardeAnja Kaiser-OsterhuesMartina JänickeNorbert Marschnernull null

Published in: European journal of haematology (2019)

Patients with DLBCL in Germany are slightly more likely to receive R-CHOP-21 than R-CHOP-14. Both schedules are similarly effective in routine practice confirming the results from RCTs.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
randomized controlled trial
primary care
healthcare
systematic review
lymph node
electronic health record
clinical practice
big data
machine learning
quality improvement